| 09.30 - 10.00 |
REGISTRATION AND INTRODUCTION |
|
| 10.00 - 11.00 |
‘Histopathological Imaging for Clinical Trials’ |
P Quirke* Leeds |
| ‘High Throughput Sequencing’ |
A Futreal*
Wellcome Sanger Institute (Hinxton) |
| ‘Predictive Profiling from FFPE Sections’ |
A Tanney* (Belfast) |
| 11.00 - 12.00 |
‘Pharmacokinetics of Targeted Therapy’ |
A Boddy* (Newcastle) |
| ‘Use of Pharmacodynamic Biomarkers to inform Clinical Decisions’ |
A Hughes*, Global Director of Drug Discovery
Astra Zeneca (UK) |
| 12.00 - 13.00 |
Translational Trials in Breast Cancer
Targeted Therapy in Renal Cancer
|
M Dowsett* (London)
B Escudier* IGR (Paris) |
| 13.00 - 13.45 |
LUNCH |
|
| 13.45 – 14.45 |
‘Tissue Banking’ Clinical Trials |
B Clark* (UK) /
A Passioukov* (EORTC) /
M Moriente* (Spain)
|
| 14.45 – 15.15 |
The ECMC and NOCI networks |
Louise Jones*(ECMC)
Lucile Serfass*(EORTC)
|
| 15.15 - 17.00 |
‘Rapporteurs Feedback’ |
R Wooster* GSK (Philadelphia)
J Tabernero* (EORTC/Barcelona)
|
| |
|
*speakers confirmed |
